BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Approval Of Unaudited Quarterly Financial Results For The 1St Quarter Ended 30.06.2019
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve Board Meeting to be held on 14.08.2019 for Approval of Unaudited Quarterly Financial Results for the 1st quarter ended 30.06.2019 Brooks Laboratories Ltd - 533543 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saras Gupta BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Conversion of Securities
Intimation of conversion of 212500 Warrants into Equity Shares BROOKS LABORATORIES LTD. - 533543 - Re-Submission Of Postal Ballot Voting Results
Re-submission of Postal Ballot Voting Results as earlier on 20.07.2019 incomplete Report was submitted due to the typographical overlook. Brooks Laboratories Ltd - 533543 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Brooks Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here BROOKS LABORATORIES LTD. - 533543 - Postal Ballot Voting Result
Postal Ballot Voting Result Volatile Wallace geared up to play with hero' Woods
At the Open, there is a lot of focus on the big guns, ranging from the seemingly unstoppable Brooks Koepka, all-time favourite Tiger Woods, to defen Brooks Laboratories Ltd - 533543 - Shareholding for the Period Ended June 30, 2019
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here BROOKS LABORATORIES LTD. - 533543 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jyoti SanchetiDesignation :- Company Secretary and Compliance Officer BROOKS LABORATORIES LTD. - 533543 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajni Ranchal